Lanthanum carbonate hydrate structure
|
Common Name | Lanthanum carbonate hydrate | ||
|---|---|---|---|---|
| CAS Number | 54451-24-0 | Molecular Weight | 475.853 | |
| Density | 2.6-2.7 | Boiling Point | N/A | |
| Molecular Formula | C3H2La2O10 | Melting Point | N/A | |
| MSDS | Chinese USA | Flash Point | N/A | |
| Symbol |
GHS07 |
Signal Word | Warning | |
| Name | Lanthanum carbonate hydrate |
|---|---|
| Synonym | More Synonyms |
| Density | 2.6-2.7 |
|---|---|
| Molecular Formula | C3H2La2O10 |
| Molecular Weight | 475.853 |
| Exact Mass | 475.777496 |
| PSA | 198.80000 |
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H315-H319-H335 |
| Precautionary Statements | P261-P305 + P351 + P338 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
| Hazard Codes | Xi |
| Risk Phrases | R36/37/38:Irritating to eyes, respiratory system and skin . |
| Safety Phrases | S26-S37/39 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
|
Effects of Sucroferric Oxyhydroxide Compared to Lanthanum Carbonate and Sevelamer Carbonate on Phosphate Homeostasis and Vascular Calcifications in a Rat Model of Chronic Kidney Failure.
Biomed Res. Int. 2015 , 515606, (2015) Elevated serum phosphorus, calcium, and fibroblast growth factor 23 (FGF23) levels are associated with cardiovascular disease in chronic renal disease. This study evaluated the effects of sucroferric ... |
| Lanthanum carbonate hydrate (2:3:1) |
| Lanthanum(III) carbonate hydrate |
| EINECS 209-599-5 |
| UNII:490D9F069T |
| Carbonic acid, lanthanum salt, hydrate (3:2:1) |
| MFCD00011069 |